HeartFlow, Inc’s Post

Watch the full video here and learn more about the benefits of utilizing lesion-specific physiology for multi-vessel disease case planning here: https://bit.ly/3WHPjpk.

From a CT scan alone you can determine the patient’s optimal treatment plan. In this case, a patient who would have normally had coronary artery bypass surgery was successfully treated with just a single vessel PCI. Watch the full video here and learn more about the benefits of utilizing lesion-specific physiology for multi-vessel disease case planning here: https://bit.ly/3WHPjpk. #HeartFlow #FFRCT #CCTA #AI #heartcare

🔬 Exploring Cutting-Edge Treatments: Iliac Vein Stenting for POTS and Pelvic Pain with Brooke Spencer🔬 This presentation dives deep into the innovative use of iliac vein stenting for managing Postural Orthostatic Tachycardia Syndrome (POTS) and pelvic pain—a topic that's gaining increasing attention in the vascular surgery community. Brooke Spencer discusses the latest advancements, patient outcomes, and the impact of iliac vein stenting on improving quality of life for those suffering from these challenging conditions. It's a must-watch for anyone interested in the future of endovascular treatments. 👥 Follow our page for more updates and view our Vumedi channel to see more sessions from TED 2024! Join the Discussion: Share your thoughts and experiences in the comments. How do you see these advancements impacting your practice? #VascularSurgery #Endovascular #POTS #PelvicPain #TEDCongress #InnovationInMedicine

The 2024 International Symposium on Endovascular Therapy educational program shared some of the latest research and data in the field. In an interview with Vascular Disease Management, Dr. Timothy Yates discusses his ISET 2024 presentation on the current data available for the use of a 35 nm laser in below-the-knee arteries in patients with critical limb ischemia: https://okt.to/w4QUHa #vasculardisease #Endovascular #ISET2024

🔬 IVC Filter Removal with Dr. Ryan Cobb 🔬 Dr. Ryan Cobb dives into the intricacies of IVC filter removal, highlighting advanced techniques, potential complications, and best practices for success. 🔔 TED 2025 will occur on February 21-23rd, 2025! Registration is now live at https://lnkd.in/gd6zu3u8. To view more sessions from TED 2024, including this one, visit VuMedi or follow our page for updates. #VascularSurgery #IVCFilterRemoval #Endovascular #TEDCongress #InnovationInMedicine

Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced the successful closing of an oversubscribed $110 million Series C to further advance its mission of bringing its innovative structural heart solution to patients. Learn about who led the funding round:

𝐏𝐨𝐥𝐥 𝐜𝐥𝐨𝐬𝐞𝐝 - 52% of respondents associated ALIF/LLIF with lower rates of repoerative ASD - but, the latest research shows, it’s not so clear cut. In last week’s poll, we asked: "Which interbody fusion technique do you associate with lower rates of reoperative ASD when treating degenerative disc disease?" In a large-scale study, “𝐴𝑟𝑒 𝑡ℎ𝑒𝑟𝑒 𝑑𝑖𝑓𝑓𝑒𝑟𝑒𝑛𝑐𝑒𝑠 𝑖𝑛 𝑡ℎ𝑒 𝑟𝑒𝑜𝑝𝑒𝑟𝑎𝑡𝑖𝑜𝑛 𝑟𝑎𝑡𝑒𝑠 𝑓𝑜𝑟 𝑜𝑝𝑒𝑟𝑎𝑡𝑖𝑣𝑒 𝑎𝑑𝑗𝑎𝑐𝑒𝑛𝑡-𝑠𝑒𝑔𝑚𝑒𝑛𝑡 𝑑𝑖𝑠𝑒𝑎𝑠𝑒 𝑏𝑒𝑡𝑤𝑒𝑒𝑛 𝐴𝐿𝐼𝐹+𝑃𝑆, 𝑃𝐿𝐼𝐹+𝑃𝑆, 𝑇𝐿𝐼𝐹+𝑃𝑆, 𝑎𝑛𝑑 𝐿𝐿𝐼𝐹+𝑃𝑆?” (JNS Spine, 40:733–740, 2024), Bains et al. found no statistically significant difference between the groups. Access the study here: https://lnkd.in/dmzcPvai While ALIF has been said to facilitate the restoration of segmental lumbar lordosis, disc height, and alignment, and potentially reduce the risk of ASD, this study - including more than 5,000 patients with a long follow up - could NOT confirm this. The origins, risk factors, and impact of interbody techniques on the reoperation rates for ASD in lumbar fusion remain elusive. This study, and others like it, challenge our assumed knowledge and show that science should lead our understanding of best practice in spine fusion surgery. At Neo, science leads every stage in our platform development process – leveraging the latest in material science and understanding to deliver the most advanced thoracolumbar fusion platform available on the market today. Visit us at neo-medical.com and find out how, together, we’re taking the next step in thoracolumbar fusion surgery! #LedByScience #NextGenTech #SpineSurgery #ThoracolumbarFusion

🔍 Interesting to see how EnChEVAR elevates ChEVAR therapy, through this 12-months evaluation of the first chimney case using Endurant™ and Radiant™. This CT scan (courtesy of Prof. Donas) showcases a significant aneurysm shrinkage, illustrating the direct impact of EnChEVAR on this patient, and an enduring patency of the chimney graft despite initial renal artery stenosis. These findings significantly contribute to our understanding of long-term outcomes in managing complex aortic diseases, and further reinforce the pivotal role of EnChEVAR in pioneering innovative treatment pathways for complex vascular conditions. #EnChEVAR #ChEVAR #VascularSurgery #Medtronic #MedtronicEmployee

#AVNeo may be the best option for young patients with aortic valve disease. Autologous pericardium, no rigid structural support retains the dynamic annular movement, excellent hemodynamics and low incidence of SVD all benefit young patients requiring aortic valve replacement, especially those patients with bicuspid valves. #Ozaki Procedure #Autologous pericardium #aortic valve neocuspidization #Bicuspid valve In this study, "TAVI outcomes in young bicuspid aortic stenosis patients are less favorable," according to De Backer. https://lnkd.in/e8aNzK7c

From diagnosis to recovery, the journey of managing glaucoma is complex, requiring a multidisciplinary approach and a focus on individual patient needs: https://lnkd.in/gbfDfWXz